Artemether-Lumefantrine Tablets from Mexico
Combination tablets containing artemether and lumefantrine, both antimalarial active principles listed in subheading note 2, put up in measured doses for retail sale. Classified under HTS 3004.60.00.00 as a mixed product for therapeutic use against Plasmodium falciparum malaria. Each pack provides a full adult treatment course.
Duty Rate — Mexico → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA approval and ensure NDC labeling for retail packs; verify active ingredients match subheading note 2 list
• Common pitfall: misclassifying as unmixed if not in fixed combo ratio
• Include stability data in documentation